Regulators approve Ubichem for commercial cGMP API production

20-Feb-2007

Ubichem Research has successfully completed its first regulatory audit and is now approved by OGYI (Hungarian National Institute for Pharmacy) for the commercial supply of cGMP active pharmaceutical ingredients (APIs). Reciprocal agreements mean that this approval is effective throughout the EU.

"This is a fantastic achievement, a real testament to the skill of our dedicated team in Budapest. Having been manufacturing quantities of API for clinical trial, this approval represents a major step forward in our business and is a clear demonstration of our commitment to quality - allowing us to support our pharma and biotech clients all the way from candidate nomination to market."

A $1-million investment in new and upgraded analytical, development and production capacity is already underway at the company's facilities. This is expected to be completed during 2007.

Other news from the department manufacturing

These products might interest you

AZURA Purifier + LH 2.1

AZURA Purifier + LH 2.1 by KNAUER

Preparative Liquid Chromatography - New platform for more throughput

Save time and improve reproducibility during purification

LC systems
Pharmaceutical Substances

Pharmaceutical Substances by Thieme Verlag

Look up Industrial Syntheses of 2,600 APIs

Your tool for Syntheses, Patents and Applications – Pharmaceutical Substances

technical literature
Loading...

Most read news

More news from our other portals

All FT-IR spectrometer manufacturers at a glance